FTSE reclassification: Nigeria is investable again—The test now is consistency

By any conventional metric, Nigeria’s return to frontier market status in the equity classification framework of FTSE Russell is a welcome development. Effective September 21, 2026, the reclassification signals a restoration of minimum investability standards after a bruising three-year stint in the “unclassified” wilderness—a period in which foreign investors were effectively locked out by prolonged dysfunction in the foreign exchange (FX) market.

To understand the significance of this moment, it is necessary to revisit the mechanism of the 2023 exclusion. Nigeria was removed from the Frontier index not because it lacked growth potential but because it failed the ultimate test of global finance: capital mobility. An FX backlog that once reached an estimated $7 billion effectively froze portfolio capital, creating a queue that stretched beyond two years. By March 2026, market participants confirmed that these queues had been cleared and that international institutional investors no longer faced material delays in repatriation.

The turnaround is the byproduct of a decisive policy shift under Central Bank of Nigeria Governor Olayemi Cardoso. His administration replaced earlier quasi-fiscal interventions with an orthodox reset anchored on price discovery and transparency. By reinforcing a market-reflective exchange rate system and clearing the verified FX backlog, the central bank has significantly narrowed the parallel market premium from over 60% in 2023 to low single digits by 2025. In effect, the reform has shifted Nigeria’s FX market from a rationing mechanism to a pricing mechanism—a fundamental requirement for sustained capital inflows.

The impact has been immediate. Foreign investment inflows surged to $23.22 billion in 2025, more than a fivefold increase from $3.91 billion in 2023, underscoring the scale of renewed investor confidence.

Nigeria’s return to frontier status is set to drive a structural rerating of the equity market, building on strong momentum that pushed Nigerian Exchange (NGX) market capitalisation above ₦100 trillion by the end of 2025. The market delivered returns exceeding 50% in 2025 and over 20% in early 2026, supported by reduced FX volatility and improving liquidity conditions. The reclassification is expected to attract passive inflows from global index-tracking funds into key stocks such as MTNN, Dangote Cement, and tier-one banks, while also drawing back active investors as improved market fundamentals reduce Nigeria’s risk premium.

Within this broader market rerating, the banking sector stands out as the clearest beneficiary. Nigerian lenders, which dominate the equity market, raised about $3.4 billion (₦4.7 trillion) in a recapitalisation drive concluded on March 31, 2026, with roughly 28% sourced from foreign investors—an early endorsement of the reform trajectory. A more functional FX market also reduces systemic stress, improves asset-liability matching for institutions with foreign currency exposure, and enhances transparency in risk pricing.

At the macroeconomic level, the implications are broader. A credible FX regime attracts portfolio inflows that support external reserves, encourages foreign direct investment, and reduces the risk premium attached to Nigerian assets. More importantly, it restores Nigeria’s standing as a functioning participant in global capital markets rather than a market on the margins.

Nigeria’s return to the Frontier index and its removal from the Financial Action Task Force grey list mark a decisive reopening of access to global capital. The policy direction of the central bank under Cardoso has begun to address long-standing structural constraints, signalling a shift toward a more transparent and market-driven framework.

The early results are encouraging. The challenge now is consistency. In global markets, credibility is not declared—it is demonstrated over time.

Ayobami Oyalowo is the Executive Director of Finance and Administration at Ogun-Oshun River Basin Development.